Funds holding TELIX PHARMACEUTICALS LTD
ISIN US87961M1053 · Australia · LEI 894500HTWOOGIHLLSB86
- Fund holders
- 5
- Of which ETFs
- 1 4 other funds
- Value held
- 4.3M $
This issuer has other securities: Telix Pharmaceuticals Ltd (AU000000TLX2)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 434,667 | 4.1M $ | 0.00 % | as of May 31, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 8,097 | 76.4K $ | 0.01 % | as of May 31, 2026 ↗ |
| RIVER OAK DISCOVERY FUND Oak Associates Funds | 5,000 | 49.5K $ | 0.26 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 4,694 | 44.3K $ | 0.00 % | as of May 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 3,943 | 39K $ | 0.01 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| RIVER OAK DISCOVERY FUND Oak Associates Funds | 0.26 % | as of Jul 31, 2026 ↗ |
| Steward Values Enhanced International Fund Steward Funds Inc | 0.01 % | as of Jul 31, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 0.01 % | as of May 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 0.00 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 5 | +3 | 456,401 | +6,086.8 % |
| 2026Q2 | 2 | -1 | 7,377 | -82.8 % |
| 2025Q3 | 3 | 42,887 |
Institutional managers
38 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 564,757 | 5.4M $ | as of Mar 31, 2026 |
| Portolan Capital Management, LLC | 541,267 | 5.2M $ | as of Mar 31, 2026 |
| LAZARD ASSET MANAGEMENT LLC | 289,917 | 2.8M $ | as of Mar 31, 2026 |
| PORTLAND INVESTMENT COUNSEL INC. | 266,200 | 2.5M $ | as of Mar 31, 2026 |
| Private Advisor Group, LLC | 174,415 | 1.7M $ | as of Mar 31, 2026 |
| Integrated Wealth Concepts LLC | 164,397 | 1.6M $ | as of Mar 31, 2026 |
| Raiffeisen Bank International AG | 130,000 | 1.2M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 116,440 | 1.1M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 57,348 | 513.8K $ | as of Mar 31, 2026 |
| Mariner, LLC | 43,446 | 415.3K $ | as of Mar 31, 2026 |
| Schonfeld Strategic Advisors LLC | 34,873 | 333.7K $ | as of Mar 31, 2026 |
| Vanguard Personalized Indexing Management, LLC | 33,253 | 318.2K $ | as of Mar 31, 2026 |
| UBS Group AG | 32,300 | 309.1K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 26,007 | 248.9K $ | as of Mar 31, 2026 |
| IHT Wealth Management, LLC | 25,035 | 239.6K $ | as of Mar 31, 2026 |
| Vident Advisory, LLC | 16,653 | 159.4K $ | as of Mar 31, 2026 |
| XY Capital Ltd | 12,552 | 120.1K $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 12,000 | 114.8K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 10,031 | 96K $ | as of Mar 31, 2026 |
| RHUMBLINE ADVISERS | 9,823 | 94K $ | as of Mar 31, 2026 |
| EverSource Wealth Advisors, LLC | 1,832 | 17.5K $ | as of Mar 31, 2026 |
| CWM, LLC | 1,425 | 13.6K $ | as of Mar 31, 2026 |
| Larson Financial Group LLC | 899 | 8.6K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 756 | 7.2K $ | as of Mar 31, 2026 |
| Blue Trust, Inc. | 742 | 7.1K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding TELIX PHARMACEUTICALS LTD". https://titelia.com/en/stocks/telix-pharmaceuticals-ltd-US87961M1053